Date: 11.8.2025
Research led by a Swansea University academic has revealed a synthetic glycosystem – a sugar-coated polymer nanoparticle – that can block COVID-19 from infecting human cells, reducing infection rates by nearly 99%.
The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid – structures that viruses often target to begin infection.
By copying this structure, the synthetic molecule acts as a decoy, binding to the virus's spike protein and preventing it from attaching to real cells.
Unlike vaccines, which trigger immune responses, this molecule acts as a physical shield, offering a novel approach to infection prevention.
Tests on human lung cells showed a 98.6% reduction in infection when the molecule was present. Crucially, the research highlighted that its effectiveness stems not just from its charge, but from its precise sugar structure – giving this glycosystem its powerful infection-blocking capability.
Image source: Khatri et al. (2025), Small.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2025 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotech Jobs - Biotechnology jobs at bio.com
Enzyme biotechnology - Information about Enzyme biotechnology
Vaccine for deadly elephant herpesvirus found safe and effective in early trial
Phage piracy uncovers new way to fight drug-resistant infections